Liu, Hao <br/><br/>
Use of Angiotensin System Inhibitors Is Associated with Immune Activation and Longer Survival in Nonmetastatic Pancreatic Ductal Adenocarcinoma.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Oct 2017 
 - 5959-5969 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-17-0256  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Angiotensins--antagonists & inhibitors<br/>Antigen-Presenting Cells--drug effects<br/>Biomarkers, Tumor--genetics<br/>Carcinoma, Pancreatic Ductal--drug therapy<br/>Disease-Free Survival<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Neoplasm Proteins--genetics<br/>Prognosis